Q2 2023 Holdings
Filed 2023-08-07 | 12 holdings | $58.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc(CNTA) | Sponsored ADS | 152309100 | $18.2M | 2,937,615 | 31.0% |
| Dice Therapeutics Inc. | Common Stock | 23345J104 | $12.5M | 268,346 | 21.3% |
| Aerovate Therapeutics Inc. | Common Stock | 008064107 | $10.4M | 603,762 | 17.7% |
| Cyteir Therapeutics, Inc. | Common Stock | 23284P103 | $6.4M | 2,459,572 | 10.9% |
| PMV Pharmaceuticals, Inc.(PMVP) | Common Stock | 69353Y103 | $6.2M | 989,232 | 10.6% |
| Vor Biopharma Inc. | Common Stock | 929033108 | $1.2M | 374,714 | 2.0% |
| Graphite Bio(GRPH) | Common Stock | 38870X104 | $1.1M | 406,308 | 1.8% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $966.0K | 862,543 | 1.6% |
| eFFECTOR Therapeutics, Inc. | Common Stock | 28202V108 | $851.5K | 1,025,697 | 1.5% |
| Precision BioSciences, Inc. | Common Stock | 74019P108 | $591.2K | 1,123,913 | 1.0% |
| Spero Therapeutics, Inc.(SPRO) | Common Stock | 84833T103 | $361.2K | 249,070 | 0.6% |
| Homology Medicines, Inc. | Common Stock | 438083107 | $56.6K | 64,000 | 0.1% |